View Older Stories View More Recent Stories
-
Eastside Distilling (EAST) PT Raised to $13 at Roth Capital
-
TekWorks Inc. Merges with Paladin Technologies Inc.
-
MeetMe (MEET) PT Raised to $8 at Roth Capital
-
Ohr Pharmaceutical (OHRP) to Merge with NeuBase Therapeutics
-
Ohr Pharmaceutical, Inc. Announces Merger Agreement with NeuBase Therapeutics, Inc.
-
Roth Capital Starts Kirkland Lake Gold (KL) at Buy
-
Tesla cuts U.S. prices on all vehicles, shares drop
-
Roth Capital Starts Dynatronics (DYNT) at Buy
-
Roth Capital Starts CannTrust Holdings Inc. (TRST:CN) (CNTTF) at Buy
-
Limoneira Company (LMNR) PT Lowered to $28 at Roth Capital
-
Roth Capital Starts Inspired Entertainment Inc (INSE) at Buy
-
Soleno Therapeutics (SLNO) Announces $16.5 Million PIPE
-
Soleno Therapeutics Announces $16.5 Million Private Placement
-
Roth Capital Starts Rimini Street (RMNI) at Buy
-
Optimizerx Corporation (OPRX) Prices 2.1M Common Stock Offering by Shareholder at $10/Share
-
OptimizeRx Announces Pricing of Public Offering of Common Stock
-
OptimizeRx Announces Pricing of Public Offering of Common Stock
-
Arch Therapeutics (ARTH) PT Raised to $3 at Roth Capital
-
Catalyst Pharmaceutical Partners (CPRX) PT Raised to $6.50 at Roth Capital
-
Roth Capital Downgrades Callaway Golf (ELY) to Neutral
-
RedHill Biopharma Announces Closing of $20 Million Underwritten Offering
-
RedHill Biopharma Announces Closing of $20 Million Underwritten Offering
-
Roth Capital Starts Endeavour Silver Corp (EDR:CN) (EXK) at Buy
-
Roth Capital Starts Endeavour Silver Corp (EDR:CN) (EXK) at Buy
-
HC2 Holdings to Participate in the 6th Annual ROTH New Industrials Corporate Access Day
-
Jason Industries, Inc. to Participate in 6th Annual ROTH New Industrials Corporate Access Day
-
Blue Bird Corp (BLBD) PT Lowered to $22 at Roth Capital
-
Roth Capital Reiterates Buy on First Solar (FSLR) Ahead of Guidance Call
-
Contango Oil & Gas (MCF) PT Lowered to $5 at Roth Capital
-
Lakeland Industries Announces Filing for Extension of Time to Report Fiscal 2019 Third Quarter Financial Results
-
RedHill Biopharma (RDHL) Prices 2.86M Offering of ADSs at $7/Share
-
RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering
-
RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering
-
Roth Capital Starts CorMedix (CRMD) at Buy
-
Roth Capital Starts BioSig Technologies Inc. (BSGM) at Buy
-
New Age Beverages Corp (NBEV) PT Raised to $11 at Roth Capital
-
ADOMANI(R) to Participate at 6th Annual ROTH New Industrials Corporate Access Day
-
SG Blocks to Participate in the 6th Annual ROTH New Industrials Corporate Access Day on December 11, 2018
-
Ambarella (AMBA) PT Raised to $40 at Roth Capital Following 3Q
-
Eastside Announces Closing of Public Offering of Common Stock
-
ShotSpotter Sets December 2018 Financial Conference Schedule
-
Roth Capital Downgrades Q BioMed (QBIO) to Neutral
-
Ameresco to Participate in the 6th Annual ROTH New Industrials Corporate Access Day
-
Renewable Energy Group to Participate at 6th Annual ROTH New Industrials Corporate Access Day
-
ROTH Capital Partners to Host 6th Annual ROTH New Industrials Corporate Access Day in New York City
-
Roth Capital Downgrades FuelCell Energy (FCEL) to Neutral
-
Roth Capital Downgrades Limbach Holdings (LMB) to Neutral
-
interCLICK (ICLK) PT Lowered to $9.25 at Roth Capital
-
UPDATE: Roth Capital Downgrades Himax Technologies (HIMX) to Neutral
-
LightPath Technologies Announces Upcoming Investor Events

